Multiple MR quantitative parameters are associated with E-cadherin expression, and Ktrans 75% is the optimal parameter to evaluate the invasion of gastric cancer. In addition, our study also determine the specific boundary range of Ktrans 75%, Ktrans mean, and Ve mean to predict whether E-cadherin expression has decreased or absented, which provides a new method to early evaluate gastric cancer invasion.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394-424.
2. Diaz Del Arco C, Estrada Munoz L, Molina Roldan E, Ceron Nieto MA, Ortega Medina L, Garcia Gomez de Las Heras S, Fernandez Acenero MJ (2018) Immunohistochemical classification of gastric cancer based on new molecular biomarkers: a potential predictor of survival. Virchows Arch 473:687-695.
3. Xing X, Tang YB, Yuan G, Wang Y, Wang J, Yang Y, Chen M (2013) The prognostic value of E-cadherin in gastric cancer: a meta-analysis. Int J Cancer 132:2589-2596.
4. Till JE, Yoon C, Kim BJ, Roby K, Addai P, Jonokuchi E, Tang LH, Yoon SS, Ryeom S (2017) Oncogenic KRAS and p53 Loss Drive Gastric Tumorigenesis in Mice That Can Be Attenuated by E-Cadherin Expression. Cancer Res 77:5349-5359.
5. Ryu HS, Park DJ, Kim HH, Kim WH, Lee HS (2012) Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer. Hum Pathol 43:520-528.
6. Park JW, Kim M-S, Voon DC, Kim S-J, Bae J, Mun D-G, Ko S-I, Kim HK, Lee S-W, Kim D-Y (2018) Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice. Molecular Carcinogenesis 57:947-954.
7. Carvalho S, Catarino TA, Dias AM, Kato M, Almeida A, Hessling B, Figueiredo J, Gartner F, Sanches JM, Ruppert T, Miyoshi E, Pierce M, Carneiro F, Kolarich D, Seruca R, Yamaguchi Y, Taniguchi N, Reis CA, Pinho SS (2016) Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer. Oncogene 35:1619-1631.
8. Ma L, Xu X, Zhang M, Zheng S, Zhang B, Zhang W, Wang P (2017) Dynamic contrast-enhanced MRI of gastric cancer: Correlations of the pharmacokinetic parameters with histological type, Lauren classification, and angiogenesis. Magn Reson Imaging 37:27-32.
9. Joo I, Lee JM, Han JK, Yang HK, Lee HJ, Choi BI (2015) Dynamic contrast-enhanced MRI of gastric cancer: Correlation of the perfusion parameters with pathological prognostic factors. J Magn Reson Imaging 41:1608-1614.
10. Setia N, Agoston AT, Han HS, Mullen JT, Duda DG, Clark JW, Deshpande V, Mino-Kenudson M, Srivastava A, Lennerz JK, Hong TS, Kwak EL, Lauwers GY (2016) A protein and mRNA expression-based classification of gastric cancer. Mod Pathol 29:772-784
Table 6 Evaluation of the efficacy of E-cadherin expression by MR quantitative parameters
Table 7 Ktrans mean, Ktrans 75%, Ve mean value to evaluate the boundary value of E-cadherin expression in gastric cancer